Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytori Therapeutics Inc (NASDAQ:CYTX)

1.55
Delayed Data
As of 9:47am ET
 -0.01 / -0.64%
Today’s Change
1.49
Today|||52-Week Range
5.70
-44.14%
Year-to-Date

Today’s Trading

Previous close1.56
Today’s open1.61
Day’s range1.50 - 1.61
Volume31,935
Average volume (3 months)114,920
Market cap$31.6M
Dividend yield--
Data as of 9:47am ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)+70.83%
Earnings growth (this year)+38.57%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-2.32%
P/E ratioNM
Price/Sales5.38
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
DXRDaxor Corp+0.30+3.55%
ARDMAradigm Corp-0.05-2.04%
MGCDMGC Diagnostics Corp+0.16+2.12%
AEMDAethlon Medical Inc0.000.00%
Data as of 9:49am ET, 12/06/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$4.8M
Annual profit (last year)-$19.4M
Net profit margin-401.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Marc H. Hedrick
CFO, Vice President &
Head-Investor Relations
Tiago Girão
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs